Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers
- 1Institute of Chemistry University of São Paulo São Paulo Brazil
- 2Institute of Environmental, Chemical and Pharmaceutical Sciences Federal University of São Paulo Diadema Brazil
Abstract
Ferroptosis as an emerging control for cell death: ferroptosis was introduced as an advanced version of regulated cell death that is defined by iron‐dependent lipid peroxidation and redox imbalance, providing a candidate for anticancer medicine because of the possibility to achieve reduction of cancer resistance with conventional therapeutic agents. Recent findings demonstrate that natural products are a prospective rich source of ferroptosis regulators through their structural variety and intrinsic redox activity. In this perspective, we present a brief overview of recent developments (from 2026 to 2021) in natural product‐induced ferroptosis and their translation into cancer treatments. Ferroptosis has been initiated via glutathione depletion, glutathione peroxidase 4 inhibition, iron accumulation, and generation of reactive oxygen species by natural compounds, such as polyphenols, alkaloids, terpenoids, and quinones. Several natural products show remarkable susceptibility to ferroptotic vulnerabilities that can sensitize drug‐resistant cancer cells to chemotherapy and radiotherapy. Moreover, the polypharmacological characteristic of natural scaffolds allows the simultaneous manipulation of interrelated metabolic and redox pathways, which enhances therapeutic efficacy. Nevertheless, bioavailability, selectivity, and mechanistic comprehension are still challenges for such interesting discoveries. Natural product‐induced ferroptosis in general is an attractive and novel alternative for promoting novel anticancer therapeutic strategies.
Related
- Targeting post-translational modifications to overcome glioblastoma therapy resistance: emerging strategies and natural compounds
- Long Non-Coding RNA LINC01614 Promotes Aggressive Phenotypes and Ferroptosis Resistance in Papillary Thyroid Cancer Through a Putative miR-4521/IGF2/PI3K-AKT Signaling Axis.
- Editorial: Novel approaches to overcome drug resistance in breast cancer
- Targeting the Tumor Microenvironment Network to Overcome Immunotherapy Resistance in Non‐Small Cell Lung Cancer: Mechanisms to Clinical Translation
- Opportunities and challenges in the development of evolving EGFR inhibitors to overcome EGFR TKIs resistance
BibTeX
@article{antoniolli2026natural,
title = {{Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers}},
author = {Giorgio Antoniolli},
journal = {Chemmedchem},
year = {2026},
month = oct,
doi = {10.1002/cmdc.70548},
url = {https://doi.org/10.1002/cmdc.70548},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Natural Product‐Induced Ferroptosis to Overcome Therapy Resistance in Aggressive Cancers
AU - Giorgio Antoniolli
PY - 2026
DA - 2026/10/01
JO - Chemmedchem
DO - 10.1002/cmdc.70548
UR - https://doi.org/10.1002/cmdc.70548
AB - Ferroptosis as an emerging control for cell death: ferroptosis was introduced as an advanced version of regulated cell death that is defined by iron‐dependent lipid peroxidation and redox imbalance, providing a candidate for anticancer medicine because of the possibility to achieve reduction of cancer resistance with conventional therapeutic agents. Recent findings demonstrate that natural products are a prospective rich source of ferroptosis regulators through their structural variety and intrinsic redox activity. In this perspective, we present a brief overview of recent developments (from 2026 to 2021) in natural product‐induced ferroptosis and their translation into cancer treatments. Ferroptosis has been initiated via glutathione depletion, glutathione peroxidase 4 inhibition, iron accumulation, and generation of reactive oxygen species by natural compounds, such as polyphenols, alkaloids, terpenoids, and quinones. Several natural products show remarkable susceptibility to ferroptotic vulnerabilities that can sensitize drug‐resistant cancer cells to chemotherapy and radiotherapy. Moreover, the polypharmacological characteristic of natural scaffolds allows the simultaneous manipulation of interrelated metabolic and redox pathways, which enhances therapeutic efficacy. Nevertheless, bioavailability, selectivity, and mechanistic comprehension are still challenges for such interesting discoveries. Natural product‐induced ferroptosis in general is an attractive and novel alternative for promoting novel anticancer therapeutic strategies.
SN - 1860-7179
SN - 1860-7187
ER -